Skip to main content

We narrowed to 777 results for: Flp recombinase

Showing: 561 - 580 of 777 results
  1. pDGB3_alpha1 nptII-DISTC02-CBS-FRT-Rep-RepA-tNos-DISTC19-CBS-miniDFR-FLP-tNos-PROXC02-pNos-CUP2-Gal4AD-tNos-SF (GB4697)

    Plasmid
    #225440
    Purpose
    Module for copper and flippase-regulated expression of BeYDV Rep/RepA, including the TU for copper-regulated FLP, the TU for constitutive expression of CUP2-GAL4, and the nptII cassette.
    Depositor
    Insert
    nptII-DISTC02-CBS-FRT:Rep/RepA:tNos-DISTC19-CBS:miniDFR:FLP:tNos-PROXC02-pNos:CUP2:Gal4AD:tNos-SF
    Use
    Synthetic Biology
    Mutation
    BsaI and BsmBI sites removed
    Available since
    Oct. 3, 2024
    Availability
    Academic Institutions and Nonprofits only
  2. pAAV-EF1a-Flpo (AAV2)

    Viral prep
    #55637-AAV2
    Purpose
    Ready-to-use AAV2 particles produced from pAAV-EF1a-Flpo (#55637). In addition to the viral particles, you will also receive purified pAAV-EF1a-Flpo plasmid DNA. EF1a-driven Flpo recombinase expression. These AAV preparations are suitable purity for injection into animals.
    Depositor
    Promoter
    EF1a
    Available since
    March 18, 2024
    Availability
    Academic Institutions and Nonprofits only
  3. pAAV.TBG.PI.FLPo.rBG (AAV8)

    Viral prep
    #236288-AAV8
    Purpose
    Ready-to-use AAV8 particles produced from pAAV.TBG.PI.FLPo.rBG (#236288). In addition to the viral particles, you will also receive purified pAAV.TBG.PI.FLPo.rBG plasmid DNA. TBG-driven expression of the recombinase FLPo. These AAV preparations are suitable purity for injection into animals.
    Promoter
    TBG
    Available since
    Oct. 23, 2025
    Availability
    Academic Institutions and Nonprofits only
  4. pAAV-CAG-FlpO (AAV Retrograde)

    Viral prep
    #183412-AAVrg
    Purpose
    Ready-to-use AAV Retrograde particles produced from pAAV-CAG-FlpO (#183412). In addition to the viral particles, you will also receive purified pAAV-CAG-FlpO plasmid DNA. CAG-driven expression of the recombinase FlpO. These AAV were produced with a retrograde serotype, which permits retrograde access to projection neurons. These AAV preparations are suitable purity for injection into animals.
    Promoter
    CAG
    Available since
    March 27, 2024
    Availability
    Academic Institutions and Nonprofits only
Showing: 561 - 580 of 777 results